Pharming PHAR
NASDAQ PHAR
$9.66 -0.09 (-0.94%)
As of: Oct 21, 2026 · 1:23 PM EDT

Pharming (PHAR) Work In Process (2020 - 2022)

Updated

Pharming's Work In Process came in at $10.85 million for Q2 2022, up 75.7% from $6.18 million a year earlier.

Analysis

Pharming (PHAR) Work In Process (2020 - 2022) Analysis & Trends

At the end of FY2021, Pharming's Work In Process was $9.61 million, up 69.5% from FY2020.

  • Going back by year, Work In Process was $5.67 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn
10 Pharming 665.36 Mn -129.01 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 10.85 Mn
Dec 31, 2021 9.61 Mn
Jun 30, 2021 6.18 Mn
Dec 31, 2020 5.67 Mn
API Access

Pharming Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=PHAR&period=max&api_key=YOUR_API_KEY